Xavier Ramnik bought MLTX
June 17, 2026 · Form 4 insider transaction
Xavier Ramnik bought 22,195 shares of MoonLake Immunotherapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
22,195
Price
$0.00
Total value
N/A
InsiderXavier Ramnik
Role—
SecurityOption to Buy
Transaction codeA: Grant or award
Transaction dateJune 17, 2026
Filing dateJune 18, 2026
Shares owned after22,195
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.